Medicine

Contact Us School of Medicine
Level 1
Trinity Biomedical Sciences Institute
Trinity College
152-160 Pearse Street
Dublin 2

View the contact page for more contact and location information

medadmin@tcd.ie
Dr. Steven Gray

Dr. Steven Gray

Clinical Senior Lecturer

Steven Gray graduated from Trinity College Dublin in 1992. He joined the laboratory of Tomas J. Ekstrom at the Karolinska Institute in 1996 and received his PhD in 2000 (Thesis Title: The IGF-axis in liver disease: Modulation of expression by histone deacetylase inhibitors). He moved to the Van Andel Research Institute in Michigan, USA where he continued his studies on the therapeutic potential of histone deacetylase inhibitors in the treatment of cancer. He also spent some time as a visting fellow at Harvard Medical School, Boston working on epigenetic therapies for neurodegenerative disease. Returning to Europe Dr Gray spent some time at the German Cancer Research Centre (DKFZ - Heidelberg), and subsequently moved to Copenhagen to work for Novo Nordisk as part of the research team of Prof Pierre De Meyts at the Hagedorn Research Institute working on epigenetic mechanisms underpinning diabetes pathogenesis. Dr Gray is currently a senior clinical scientist at St James's Hospital in the Deprtment of Clinical Oncology at the Thoraacic Oncology Research Group at St. James's Hospital headed by Dr. Sinead Cuffe and Professor Stephen Finn, and holds an adjunct assistant professorship with the Dept of Clinical Medicine (TCD).

Publications and Further Research Outputs

  • MacDonagh,Lauren , Gray,Steven George, Finn,Stephen P. , Cuffe,Sinead D. , O'Byrne,Kenneth John, Barr,Martin P. , The emerging role of microRNAs in resistance to lung cancer treatments, Cancer Treatment Reviews, 41, (2), 2015, p160-169Journal Article, 2015, DOI
  • Zhao, Jun , Greene, Catherine M. , Gray, Steven George , Lawless, Matthew William, Long noncoding RNAs in liver cancer: What we know in 2014, Expert Opinion on Therapeutic Targets, 18, (10), 2014, p1207-1218Journal Article, 2014, DOI
  • Gray,Steven George S.G., Epigenetic-based immune intervention for rheumatic diseases, Epigenomics, 6, (2), 2014, p253-271Journal Article, 2014, DOI
  • Gray,Steven George S.G., Perspectives on epigenetic-based immune intervention for rheumatic diseases, Arthritis Research and Therapy, 15, (2), 2013, p207Journal Article, 2013, DOI
  • Barr, M.P., Gray, S.G., Gately, K., (...), Pidgeon, G.P., O'Byrne, K.J., Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer, Molecular Cancer, 14, (1), 2015, p45-Journal Article, 2015, DOI , TARA - Full Text
  • MacDonagh L, Gray SG, Breen E, Cuffe S, Finn SP, O'Byrne KJ, Barr MP, Lung cancer stem cells: The root of resistance., Cancer letters, 372, (2), 2016, p147-56Journal Article, 2016, DOI
  • Quinn L, Finn SP, Cuffe S, Gray SG, Non-coding RNA repertoires in malignant pleural mesothelioma., Lung cancer (Amsterdam, Netherlands), 90, (3), 2015, p417-26Journal Article, 2015
  • Cregan S, McDonagh L, Gao Y, Barr MP, O'Byrne KJ, Finn SP, Cuffe S, Gray SG, KAT5 (Tip60) is a potential therapeutic target in malignant pleural mesothelioma., International journal of oncology, 48, (3), 2016, p1290-6Journal Article, 2016, DOI
  • Baird AM, Gray SG, Richard DJ, O'Byrne KJ, Promotion of a cancer-like phenotype, through chronic exposure to inflammatory cytokines and hypoxia in a bronchial epithelial cell line model., Scientific reports, 6, 2016, p18907Journal Article, 2016, DOI , TARA - Full Text
  • Perry AS, Baird AM, Gray SG, Epigenetic Methodologies for the Study of Celiac Disease., Methods in molecular biology (Clifton, N.J.), 1326, 2015, p131-58Journal Article, 2015
  • Introduction in, editor(s)Steven G. Gray , Epigenetic Cancer Therapy, 1st Edition, Academic Press, 2015, pp1 - 6, [Steven G. Gray]Book Chapter, 2015
  • Chapter 9. Epigenetic Therapy in Lung Cancer and Mesothelioma in, editor(s)Steven G. Gray , Epigenetic Cancer Therapy, 1st Edition. , Academic Press, 2015, pp189 - 213, [Anne-Marie Baird, Derek Richard, Kenneth J. O'Byrne, Steven G. Gray]Book Chapter, 2015
  • Chapter 26. Epigenetics of Cisplatin Resistance. in, editor(s)Stevn G. Gray , Epigenetic Cancer Therapy, 1st Edition. , Academic Press, 2015, pp613 - 637, [Steven G. Gray]Book Chapter, 2015
  • Joerger, M., Finn, S.P., Cuffe, S., Byrne, A.T., Gray, S.G., The IL-17-Th1/Th17 pathway: an attractive target for lung cancer therapy?, Expert Opinion on Therapeutic Targets, 20, (11), 2016, 1339-1356Journal Article, 2016, DOI
  • Gray, S.G., Cuffe, S., Finn, S.P., PD-L1 as a companion biomarker for immune checkpoint inhibitors in NSCLC: Should RNA ISH (RISH) be considered?, Journal of Thoracic Oncology, 11, (11), 2016, e142-e144Journal Article, 2016, DOI
  • Cregan S, Breslin M, Roche G, Wennstedt S, MacDonagh L, Albadri C, Gao Y, O'Byrne K.J, Cuffe S, Finn S.P, Gray S.G, Kdm6a and Kdm6b: Altered expression in malignant pleural mesothelioma, International Journal of Oncology, 50, (3), 2017, p1044 - 1052Journal Article, 2017, DOI , URL
  • Quinn Leah, Gray Steven G, Meaney Steve, Finn Stephen, McLoughlin Padraig, Hayes Maria, Extraction and Quantification of Sinapinic Acid from Irish Rapeseed Meal and Assessment of Angiotensin-I Converting Enzyme (ACE-I) Inhibitory Activity , Journal of agricultural and food chemistry , 65 , (32 ), 2017, p6886 - 6892Journal Article, 2017, DOI , URL
  • Greene John, Baird Anne-Marie, Brady Lauren, Lim Marvin, Gray Steven G, McDermott Raymond, Finn Stephen P, Circular RNAs: Biogenesis, Function and Role in Human Diseases , Frontiers in molecular biosciences , 4 , 2017, p38 -Journal Article, 2017, DOI , URL
  • Heery Richard, Finn Stephen P, Cuffe Sinead, Gray Steven G, Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells , Cancers , 9 , (4 ), 2017, p38-Journal Article, 2017, DOI , URL , TARA - Full Text
  • MacDonagh L, Gray SG, Breen E, Cuffe S, Finn SP, O'Byrne KJ, Barr MP, Exploitation of the vitamin A/retinoic acid axis depletes ALDH1-positive cancer stem cells and re-sensitises resistant non-small cell lung cancer cells to cisplatin., Translational Oncology, 14, (4), 2021, p101025-Journal Article, 2021
  • Gray, S.G. and Wright, M.C. and Finn, S.P., The "eyes" have it?-intra- and inter-observer reproducibility of the PD-L1 companion diagnostic assay, Translational Cancer Research, 6, 2017, pS1027-S1029Journal Article, 2017, DOI , URL
  • Dockry É, O'Leary S, Gleeson LE, Lyons J, Keane J, Gray SG, Doherty DG, Epigenetic induction of CD1d expression primes lung cancer cells for killing by invariant natural killer T cells, OncoImmunology, 2018, pe1428156-Journal Article, 2018, URL
  • MacDonagh, L. and Gray, S.G. and Breen, E. and Cuffe, S. and Finn, S.P. and O'Byrne, K.J. and Barr, M.P., BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC, Cancer Letters, 428, 2018, p117-126Journal Article, 2018, DOI , URL
  • Singh, A.S. and Heery, R. and Gray, S.G., In silico and in vitro analyses of lncRNAs as potential regulators in the transition from the epithelioid to sarcomatoid histotype of malignant pleural mesothelioma (MPM), International Journal of Molecular Sciences, 19, (5), 2018, p1297-Journal Article, 2018, DOI , URL , TARA - Full Text
  • Letovanec, I. and Finn, S. and Zygoura, P. and Smyth, P. and Soltermann, A. and Bubendorf, L. and Speel, E.-J. and Marchetti, A. and Nonaka, D. and Monkhorst, K. and Hager, H. and Martorell, M. and Sejda, A. and Cheney, R. and Hernandez-Losa, J. and Verbeken, E. and Weder, W. and Savic, S. and Di Lorito, A. and Navarro, A. and Felip, E. and Warth, A. and Baas, P. and Meldgaard, P. and Blackhall, F. and Dingemans, A.-M. and Dienemann, H. and Dziadziuszko, R. and Vansteenkiste, J. and O'Brien, C. and Geiger, T. and Sherlock, J. and Schageman, J. and Dafni, U. and Kammler, R. and Kerr, K. and Thunnissen, E. and Stahel, R. and Peters, S. and Stahel, R.A. and Rosell, R. and Blackhall, F. and Dafni, U. and Kerr, K.M. and Molina, M.Ã . and Bubendorf, L. and Weder, W. and Thunnissen, E. and Peters, S. and Finn, S. and Hiltbrunner, A. and Kammler, R. and Geiger, T. and Marti, N. and Dafni, U. and Tsourti, Z. and Polydoropoulou, V. and Zygoura, P. and Finn, S. and Smyth, P. and O'Brien, C. and Gray, S. and Weder, W. and Soltermann, A. and Opitz, I. and Curioni, A. and Bubendorf, L. and Savic, S. and Lardinois, D. and Dingemans, A.-M. and Speel, E.-J.M. and Ruland, A. and Marchetti, A. and Di Lorito, A. and De Luca, G. and Malatesta, S. and Blackhall, F. and Nonaka, D. and Quinn, A.M. and Franklin, L. and Biernat, W. and Wrona, A. and Rzyman, W. and Jassem, J. and Meldgaard, P. and Hager, H. and Madsen, L.B. and Camps, C. and Martorell, M. and Jantus-Lewintre, E. and Guijarro, R. and Kerr, K.M. and Nicolson, M. and Stevenson, D.A.J. and Mathieson, W. and Baas, P. and de Jong, J. and Monkhorst, K. and Thunnissen, E. and Smit, E. and van Setten, C. and de Langen, J. and Felip, E. and Hernandez-Losa, J. and Sansano, I. and Cheney, R. and Pine, M.B. and Reid, M. and Taylor, E. and Nackaerts, K. and Dooms, C. and Wauters, E. and Van Der Borght, S. and Dienemann, H. and Muley, T. and Warth, A., Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project, Journal of Thoracic Oncology, 13, (3), 2018, pe33-e34Journal Article, 2018, DOI , URL , TARA - Full Text
  • John Aird, Anne-Marie Baird, Marvin C.J. Lim, Ray McDermott, Stephen P. Finn, Steven G. Gray, Carcinogenesis in prostate cancer: The role of long non-coding RNAs, Non-coding RNA Research, 3, (1), 2018, p29--38Journal Article, 2018
  • Kerr K.M, Thunnissen E, Dafni U, Finn S.P, Bubendorf L, Soltermann A, Verbeken E, Biernat W, Warth A, Marchetti A, Speel E.-J.M, Pokharel S, Quinn A.M, Monkhorst K, Navarro A, Madsen L.B, Radonic T, Wilson J, De Luca G, Gray S.G, Cheney R, Savic S, Martorell M, Muley T, Baas P, Meldgaard P, Blackhall F, Dingemans A.-M, Dziadziuszko R, Vansteenkiste J, Weder W, Polydoropoulou V, Geiger T, Kammler R, Peters S, Stahel R, A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project, Lung Cancer, 131, 2019, p95 - 103Journal Article, 2019, DOI , URL
  • Zhao J, Gray S.G, Greene C.M, Lawless M.W, Unmasking the pathological and therapeutic potential of histone deacetylases for liver cancer, Expert Review of Gastroenterology and Hepatology, 13, (3), 2019, p247 - 256Journal Article, 2019, DOI , URL
  • Gray S.G, We're Stressed Out: BET-Ting on Oxidative Stress?, BioEssays, 40, (5), 2018Journal Article, 2018, DOI , URL
  • Ryan, S.-L. and Beard, S. and Barr, M.P. and Umezawa, K. and Heavey, S. and Godwin, P. and Gray, S.G. and Cormican, D. and Finn, S.P. and Gately, K.A. and Davies, A.M. and Thompson, E.W. and Richard, D.J. and O'Byrne, K.J. and Adams, M.N. and Baird, A.-M., Targeting NF-KB-mediated inflammatory pathways in cisplatin-resistant NSCLC, Lung Cancer, 135, 2019, p217-227Journal Article, 2019, DOI , URL
  • Baird AM, Easty D, Jarzabek M, Shiels L, Soltermann A, Klebe S, Raeppel S, MacDonagh L, Wu C, Griggs K, Kirschner MB, Stanfill B, Nonaka D, Goparaju CM, Murer B, Fennell DA, O'Donnell DM, Barr MP, Mutti L, Reid G, Finn S, Cuffe S, Pass HI, Opitz I, Byrne AT, O'Byrne KJ, Gray SG., When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?, Frontiers in endocrinology, 10, 2019, p89Journal Article, 2019, DOI
  • Thunnissen E, Kerr KM, Dafni U, Bubendorf L, Finn SP, Soltermann A, Biernat W, Cheney R, Verbeken E, Warth A, Marchetti A, Speel EM, Pokharel S, Quinn AM, Monkhorst K, Navarro A, Madsen LB, Tsourti Z, Geiger T, Kammler R, Peters S, Stahel RA; European Thoracic Oncology Platform Lungscape Consortium., Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I-III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort., Modern Pathology, 33, (5), 2020, p792 - 801Journal Article, 2020
  • Thunnissen E, Kerr KM, Dafni U, Bubendorf L, Finn SP, Soltermann A, Biernat W, Cheney R, Verbeken E, Warth A, Marchetti A, Speel EM, Pokharel S, Quinn AM, Monkhorst K, Navarro A, Madsen LB, Tsourti Z, Geiger T, Kammler R, Peters S, Stahel RA; European Thoracic Oncology Platform Lungscape Consortium., Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I-III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort., Modern Pathology, 33, (5), 2020, p792 - 801Journal Article, 2020
  • Takahashi, M., Gray, S.G., Yuhas, J., Qian, C-N., Kanayama, H., Kagawa, S., Teh, B.T., Altered expression of members of the IGF-axis in Renal Cell Carcinoma, International Journal of Oncology, 26, (4), 2005, p923 - 931Journal Article, 2005
  • Gray, S.G., Qian, C-N., Furge, K., Guo, X. and Teh, B.T., Microarray profiling of the effects of histone deacetylase inhibitors on gene expression in cancer cell lines, International Journal of Oncology, 24, (4), 2004, p773 - 795Journal Article, 2004
  • Gray, S.G., Mathiasen, I.S., and De Meyts, P.D, The Insulin-like Growth Factors and Insulin-signalling Systems: An Appealing Target for Breast Cancer Therapy?, Hormone and Metabolic Research, 35, (11-12), 2003, p857 - 871Journal Article, 2003, DOI
  • Histone Acetyltransferases and Histone Deacetylases in Gene Regulation and as Drug Targets in, editor(s)Vincent T. DeVita, Jr., M.D. Samuel Hellman, M.D. Steven A. Rosenberg, M.D., Ph.D. , Progress in Oncology, USA, Jones and Bartlett , 2004, pp99 - 128, [Gray, S.G.]Book Chapter, 2004
  • Takahashi, M., Yang, X. J., Sugimura, J., Backdahl, J., Tretiakova, M., Qian, C-N., Gray, S. G., Knapp, R., Anema, J., Kahnoski, R., Nicol, D., Vogelzang, N. J., Furge, K. A., Kanayama, H., Kagawa, S., Teh, B. T. , Molecular sub-classification of kidney cancers and the discovery of new diagnostic markers, Oncogene, 22, (43), 2003, p6810 - 6818Journal Article, 2003, DOI
  • Gray, S.G., Iglesias, A., Teh, B.T., and Dangond, F., Modulation of Splicing Events in Histone Deacetylase 3 by various Extracellular and Signal Transduction Pathways, Gene Expression, 11, (1), 2003, p13 - 21Journal Article, 2003
  • Svechnikova, I., Gray, S. G., Kundrotiene, J., Ponthan, F., Kogner, P. and Ekström, T. J., Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrate, International Journal of Oncology, 22, 2003, p579 - 588Journal Article, 2003
  • Guo, X., Lui, W-O., Qian, C-N., Chen, J-D., Gray, S.G., Rhodes, D., Haab, B., Stanbridge, E., Wang, H., Hong, M-H., Min, H-Q., Larsson, C., and Teh, B.T., Identifying cancer-related genes in nasopharyngeal carcinoma cell lines using DNA and mRNA expression profiling analyses, International Journal of Oncology, 21, 2002, p1197 - 1204Journal Article, 2002
  • Gray, S.G. and De Meyts, P., Role of histone and transcription factor acetylation in diabetes pathogenesis, Diabetes and Metabolism Research and Reviews, 21, (5), 2005, p416 - 433Journal Article, 2005, DOI , URL
  • Camelo S, Iglesias AH, Hwang D, Due B, Ryu H, Smith K, Gray SG, Imitola J, Duran G, Assaf B, Langley B, Khoury SJ, Stephanopoulos G, De Girolami U, Ratan RR, Ferrante RJ, Dangond F, Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis., Journal of Neuroimmunology, 164, (1-2), 2005, p10 - 21Journal Article, 2005, DOI
  • von Horn, H., Hwa, V., Rosenfeld, R. G., Hall, K., Teh, B. T., Tally, M., Ekström, T.J., and Gray, S.G. , Altered expression of low affinity insulin-like growth factor binding protein related proteins in hepatoblastomas, International Journal of Molecular Medicine, 9, (6), 2002, p645 - 649Journal Article, 2002
  • Hartmann, W., Waha, A., Koch, A., Gray, S.G., Ekström, T.J., von Schweinitz, D., and Pietsch, T., Promoter-specific transcription of the IGF2 gene: a novel rapid, non-radioactive and highly sensitive protocol for mRNA analysis, Virchows Archiv, 439, 2001, p803 - 807Journal Article, 2001, DOI
  • Eriksson, T., Frisk, T., Gray, S.G., von Schweinitz, D., Pietsch, T., Larsson, C., Sandstedt, B. and Ekström, T.J., Methylation Changes in the Human IGF2 P3 Promoter Parallel IGF2 Expression in the Primary Tumor, Established Cell Line, and Xenograft of a Human Hepatoblastoma , Experimental Cell Research, 270, (1), 2001, p88 - 95Journal Article, 2001, DOI
  • Dangond, F., Henriksson, M., Zardo, G., Caiafa, P. Ekström, T.J.,and Gray, S.G., Differential expression of class I HDACs: roles of cell density and cell cycle, International Journal of Oncology, 19, (4), 2001, p773 - 777Journal Article, 2001
  • Gray, S.G. and Teh, B. T., Histone Acetylation/Deacetylation and cancer: An "open" and "shut" case?, Current Molecular Medicine, 1, (4), 2001, p401 - 429Journal Article, 2001, URL
  • Gray, S.G., Guo, X., Kedra, D., Min, H-Q., and Teh, B.T., Correspondence re: P.P. Claudio et al., Mutations in the retinoblastoma-related gene RB2/p130 in primary nasopharyngeal carcinoma, Cancer Research, 61, (15), 2001, p6950 - 6952Journal Article, 2001, URL
  • Gray, S.G. and Ekström T. J., The Human Histone Deacetylase Family, Experimental Cell Research, 262, 2001, p75 - 83Journal Article, 2001, DOI
  • von Horn, H., Tally, M., Hall, K., Ekström, T.J., and Gray, S.G., Expression levels of insulin-like growth factor binding proteins and insulin receptor isoforms in hepatoblastomas, Cancer Letters, 162, (2), 2001, p253 - 260Journal Article, 2001, DOI
  • Gray, S.G., Kytölä, S., Matsunaga, T., Larsson, C. and Ekström, T.J. , Comparative genomic hybridization reveals population based genetic alterations in hepatoblastomas, British Journal of Cancer, 83, 2000, p1020 - 1025Journal Article, 2000
  • Gray, S.G., Hartman, W., Kytölä, S., Eriksson, T., Ekström, C., von Schweinitz, D., Kogner, P., Sandstedt, B., Larsson, C., Pietsch, T., and Ekström, T.J., Expression of genes involved with cell cycle control, cell growth and chromatin modification are altered in hepatoblastomas, International Journal of Molecular Medicine, 6, 2000, p161 - 169Journal Article, 2000
  • Gray, S.G., Svechnikova, I., Hartmann, W., Aguilar-Santileses, M. and Ekström, T.J., IGF-II and IL-2 act synergistically to alter HDAC1 expression following treatments with Trichostatin A, Cytokine, 12, (7), 2000, p1104 - 1109Journal Article, 2000, DOI
  • Gray, S.G., Kytölä, S., Weng O L., Larsson, C., and Ekström, T.J., Modulating IGFBP-3 expression by Trichostatin A: Potential therapeutic role in the treatment of Hepatocellular carcinoma, International Journal of Molecular Medicine, 5, (1), 2000, p33 - 41Journal Article, 2000
  • Gray, S.G., Yakovleva, T., Hartmann, W., Tally, M., Bakalkin, G., and Ekström, T.J., IGF-II enhances trichostatin A-induced TGFβ1 and p21(Waf1/Cip1/Sdi1) expression in Hep3B cells, Experimental Cell research, 253, (2), 1999, p618 - 628Journal Article, 1999, DOI
  • Gray, S.G., Eriksson, E., and Ekström, T.J., Methylation, gene expression and the chromatin connection in cancer, International Journal of Molecular Medicine, 4, (4), 1999, p333 - 350Journal Article, 1999, URL
  • Kjellman, M., Roshani, L., Teh, B.T., Kallioniemi, O-P., Höög, A., Gray, S., Farnebo, L-O., Holst, M., Bäckdahl, M., and Larsson, C., Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1 cM region in 2p16., The Journal of clinical endocrinology and metabolism, 84, (2), 1999, p730 - 735Journal Article, 1999, DOI
  • Betz, R., Gray, S.G., Larsson, C., and Ekström, T. J. , Human Histone Deacetylase 2, HDAC2 (hRPD3), is located to 6q21 by Radiation Hybrid Mapping, Genomics, 52, 1998, p245 - 246Journal Article, 1998
  • Li, X., Gray, S.G., Flam, F., Pietsch, T., and Ekström, T. J., Developmental-dependent DNA methylation of the IGF2 and H19 promoters is correlated to the promoter activities in human liver development, International Journal of Developmental Biology, 42, (5), 1998, p687 - 693Journal Article, 1998, URL
  • Gray, S.G., and Ekström, T. J., Effects of Cell Density and TrichostatinA on the Expression of HDAC1 and p57Kip2 in Hep 3B Cells, Biochemical and Biophysical Research Communications, 245, (2), 1998, p423 - 427Journal Article, 1998, DOI
  • Gray, S.G., Kjellman, M., Larsson, C., and Ekström, T. J., Novel splicing of an IGF2 polymorphic region in human adrenocortical carcinomas, Biochemical and Biophysical Research Communications, 239, (3), 1997, p878 - 883Journal Article, 1997, DOI
  • Baird AM, Finn SP, Gray SG, Sheils O., Epigenetic Modifier UHRF1 May Be a Potential Target in Malignant Pleural Mesothelioma., Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 16, (1), 2021, p14-16Journal Article, 2021, DOI
  • John Greene, Anne-Marie Baird, Marvin Lim, Joshua Flynn, Ciara McNevin, Lauren Brady, Orla Sheils, Steven G Gray, Raymond McDermott, Stephen P Finn, Differential CircRNA Expression Signatures May Serve as Potential Novel Biomarkers in Prostate Cancer, Frontiers in cell and developmental biology, 9, 2021, p334-Journal Article, 2021
  • MacDonagh L, Gallagher MF, Ffrench B, Gasch C, Gray SG, Reidy M, Nicholson S, Leonard N, Ryan R, Young V, O'Leary JJ, Cuffe S, Finn SP, O'Byrne KJ, Barr MP., MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancer., Translational lung cancer research, 10, (4), 2021, p1773-1791Journal Article, 2021, DOI
  • Perryman L, Gray SG., Fibrosis in Mesothelioma: Potential Role of Lysyl Oxidases. , Cancers, 14, (4), 2022, p981Journal Article, 2022, DOI
  • Meirson T, Pentimalli F, Cerza F, Baglio G, Gray SG, Correale P, Krstic-Demonacos M, Markel G, Giordano A, Bomze D, Mutti L., Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma., JAMA Netw Open, 5, (3), 2022, pe221490Journal Article, 2022, DOI
  • Sui JSY, Finn SP, Gray SG., Detection of MET Exon 14 Skipping Alterations in Lung Cancer Clinical Samples Using a PCR-Based Approach., Methods in molecular biology (Clifton, N.J.), 2279, 2021, p145-155Journal Article, 2021, DOI
  • Oner E, Kotmakci M, Baird AM, Gray SG, Debelec Butuner B, Bozkurt E, Kantarci AG, Finn SP., Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small-molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids., Journal of nanobiotechnology, 19, (71), 2021, p1-20Journal Article, 2021, DOI , URL , TARA - Full Text
  • Gray SG., Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma., BMC pulmonary medicine, 21, (1), 2021, p148Journal Article, 2021, DOI
  • Porta C, Nardone V, Gray SG, Correale P, Mutti L., RAMES study: is there really a role for VEGF inhibition in mesothelioma?, The Lancet. Oncology, 22, (12), 2021, pe532Journal Article, 2021, DOI
  • Lim MCJ, Baird AM, Greene J, McNevin C, Ronan K, Podlesniy P, Sheils O, Gray SG, McDermott RS, Finn SP., hsa_circ_0001275 Is One of a Number of circRNAs Dysregulated in Enzalutamide Resistant Prostate Cancer and Confers Enzalutamide Resistance In Vitro. , Cancers, 13, (24), 2021, p6383Journal Article, 2021, DOI
  • Sui JSY, Martin P, Gray SG., Pre-clinical models of small cell lung cancer and the validation of therapeutic targets., Expert opinion on therapeutic targets, 24, (3), 2020, p187-204Journal Article, 2020, DOI
  • Gray SG, Mutti L., Immunotherapy for mesothelioma: a critical review of current clinical trials and future perspectives., Translational lung cancer research, 9, (suppl 1), 2020, pS100-S119Journal Article, 2020, DOI
  • Chellamuthu A, Gray SG., The RNA Methyltransferase NSUN2 and Its Potential Roles in Cancer. , Cells, 9, (8), 2020, pE1758Journal Article, 2020, DOI
  • Burgess JT, Bolderson E, Adams MN, Duijf PHG, Zhang SD, Gray SG, Wright G, Richard DJ, O'Byrne KJ., SASH1 is a prognostic indicator and potential therapeutic target in non-small cell lung cancer., Scientific reports, 10, (1), 2020, p18605Journal Article, 2020, DOI
  • Felley-Bosco E, Gray SG., Mesothelioma Driver Genes, Ferroptosis, and Therapy., Frontiers in oncology, 9, 2019, p1318Journal Article, 2019, DOI
  • Gray SG., Squaring the circle: sponging microRNAs in gastric cancer., Translational cancer research, 8, (suppl 2), 2019, pS183-S187Journal Article, 2019, DOI
  • "Malignant pleural mesothelioma: clinical presentation, radiological evaluation and diagnosis" in, editor(s)Kenneth O'Byrne, Consultant Oncologist, Hope Directorate, St James's Hospital, Dublin, Ireland Valerie Rusch, Chief of the Thoracic Service Surgery, William G Cahan Chair, Memorial Sloan-Kettering Cancer Center, New York, USA , Malignant Pleural Mesothelioma , Great Clarendon Street, Oxford OX2 6DP, Oxford University Press, 2006, pp35 - 60, [Michael D. Peake, James Entwisle, and Steven Gray]Book Chapter, 2006, URL
  • Gray S.G., Iglesias AH, Lizcano F, Villanueva R, Camelo S, Jingu H, Teh BT, Koibuchi N, Chin WW, Kokkotou E, Dangond F. , Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein., Journal of Biological Chemistry, 280, (31), 2005, p28507 - 28518Journal Article, 2005, DOI
  • Greulich-Bode, K.M., Moshir, S., Figueroa, R., Cerezo, A., Lindenmaier, H., Stark, H-J., Gray, S.G., Vang Nilsen, K., Hartschuh, W., and Boukamp, P. , Differential Regulation of Telomere Length and Telomerase Activity in Normal Skin Keratinocytes In Vivo and In Vitro, 2006Journal Article, 2006
  • Gray, S.G., and Dangond, F. , Rationale for the Use of Histone Deacetylase Inhibitors as a Therapeutic Modality in Multiple Sclerosis, Epigenetics, 1, (2 I), 2006, p67-75Journal Article, 2006, URL
  • Villanueva, R., Iglesias, A., Camelo, S., Sanin, L.C. Gray, S.G. and Dangond, F. , Histone deacetylase 3 represses HTLV-1 tax transcription. , Oncology Reports, 16, (3), 2006, p581-585Journal Article, 2006, URL
  • Shaukat Mahmood, Steven G. Gray, Rehannah Borup, Martin Wabitsch, Hans E. Tornqvist, Pierre De Meyts, Gene expression profiling of adipocyte/preadipocyte responses to Insulin and IGF-I signalling, Systems Biology: Integrating Biology, Technology and Computation (C6), Taos, New Mexico, USA, 05/03/06 - 10/03/06, 2006Poster, 2006
  • Histone deacetylase inhibitors as a therapeutic modality in multiple sclerosis in, editor(s)Dr. Serena Guiducci & Dr Moncef Zouali , The Epigenetics of Autoimmune Diseases, Wiley Press, 2009, pp403 - 432, [Gray, S.G.]Book Chapter, 2009
  • Lawless, MW, Norris, S, O'Byrne, KJ, Gray, SG, Targeting histone deacetylases for the treatment of immune, endocrine & metabolic disorders., Endocrine, metabolic & Immune Disorders Drug Targets, 9, (1), 2009, p84-107Journal Article, 2009, DOI
  • Gray, SG, Fennell, DA, Mutti, L, O'Byrne, KJ, In arrayed ranks: array technology in the study of mesothelioma., Journal of Thoracic Oncology : official publication of the International Association for the Study of Lung Cancer, 4, (3), 2009, p411-425Journal Article, 2009, DOI , URL
  • Lawless, MW, Norris, S, O'Byrne, KJ, Gray, SG, "Targeting Histone Deacetylases for the treatment of disease", Journal of cellular and molecular medicine, 2008Journal Article, 2008, DOI
  • Gray, SG, Al-Sarraf, N, Baird, AM, Gately, K, McGovern, E, O'Byrne, KJ, Transcriptional regulation of IRS5/DOK4 expression in non-small-cell lung cancer cells., Clinical lung cancer, 9, (6), 2008, p367-374Journal Article, 2008, DOI
  • Lawless, MW, Mankan, AK, Gray, SG, Norris, S, Endoplasmic reticulum stress--a double edged sword for Z alpha-1 antitrypsin deficiency hepatoxicity., The international journal of biochemistry & cell biology, 40, (8), 2008, p1403-1414Journal Article, 2008, DOI
  • Gray, SG, Dangond, F, Rationale for the use of histone deacetylase inhibitors as a dual therapeutic modality in multiple sclerosis., Epigenetics : official journal of the DNA Methylation Society, 1, (2), 2006, p67-75Journal Article, 2006, URL
  • Al-Sarraf, N, Reiff, JN, Hinrichsen, J, Mahmood, S, Teh, BT, McGovern, E, De Meyts, P, O'byrne, KJ, Gray, SG, DOK4/IRS-5 expression is altered in clear cell renal cell carcinoma., International journal of cancer. Journal international du cancer, 121, (5), 2007, p992-998Journal Article, 2007, DOI
  • Gray, S.G., Crowe, J., Lawless, M.W., Hemochromatosis: As a conformational disorder , International Journal of Biochemistry and Cell Biology , 2009Journal Article, 2009, DOI
  • Mankan, A.K., Lawless, M.W., Gray, S.G., Kelleher, D., McManus, R., NF-κB regulation: The nuclear response , Journal of Cellular and Molecular Medicine , 13, (4), 2009, p631-643Journal Article, 2009, DOI , URL , TARA - Full Text
  • Krunic, D., Moshir, S., Greulich-Bode, K.M., Figueroa, R., Cerezo, A., Stammer, H., Stark, H.-J., (...), Boukamp, P., Tissue context-activated telomerase in human epidermis correlates with little age-dependent telomere loss , Biochimica et Biophysica Acta - Molecular Basis of Disease, 1792, (4), 2009, p297-308Journal Article, 2009, DOI
  • Mahmood, S., Borup, R., Gray, S.G., and De Meyts, P., Gene expression profiling of human adipocyte responses to insulin and IGF-I signalling., The Open Diabetes Journal, 2, 2009, p5-17Journal Article, 2009, DOI
  • Lawless, M. W., Norris, S., O'Byrne, K.J. and Gray, S.G., Histone Deacetylase inhibitors for the treatment of disease, Journal of Cellular and Molecular Medicine, 2009Journal Article, 2009
  • Lawless, M., Norris, S., O'Byrne, K.J and Gray, S.G., Targeting epigenetic pathways in obesity and diabetes, Cellscience Reviews, 4, (3), 2008, p119-166Journal Article, 2008, URL
  • Gray, S.G. , DMMC workshop: unravelling chromatin and the role of epigenetics in disease., Epigenetics : official journal of the DNA Methylation Society, 1, (4), 2006, p187-189Journal Article, 2006
  • Gray, S.G. , Erratum: The Insulin-like Growth Factors and Insulin-signalling Systems: An Appealing Target for Breast Cancer Therapy (Hormone and Metabolic Research (2003) 35 (857-871)) , Hormone and Metabolic Research, 36, (1), 2004, p74Journal Article, 2004, DOI
  • Wang, Y., Rea, T., Bian, J., Gray, S., Sun, Y. , Identification of the genes responsive to etoposide-induced apoptosis: Application of DNA chip technology, FEBS Letters , 445, (2-3), 1999, p269-273Journal Article, 1999, DOI
  • Gray, S.G., Eriksson, T., Ekström, C., Holm, S., Von Schweinitz, D., Kogner, P., Sandstedt, B., (...), Ekström, T.J. , Altered expression of members of the IGF-axis in hepatoblastomas, British Journal of Cancer , 82, (9), 2000, p1561-1567Journal Article, 2000, DOI
  • Anne-Marie Baird, Steven G. Gray, Kenneth J. O'Byrne, Epigenetics Underpinning the Regulation of the CXC (ELR+) Chemokines in Non-Small Cell Lung Cancer, PLoS One, 6, (1), 2011, pe14593Journal Article, 2011, DOI , URL , TARA - Full Text
  • Easty DJ, Gray SG, O'Byrne KJ, O'Donnell D, Bennett DC, Receptor tyrosine kinases and their activation in melanoma., Pigment Cell & Melanoma Research, 24, (3), 2011, p446-461Journal Article, 2011, DOI , URL , TARA - Full Text
  • O'Byrne KJ, Barr MP, Gray SG., The role of epigenetics in resistance to cisplatin chemotherapy in lung cancer, Cancers, 3, (1), 2011, p1426 - 1453Journal Article, 2011, DOI , URL , TARA - Full Text
  • KJ O'Byrne, The Role of Epigenetics in Resistance to Cisplatin Chemotherapy in Lung Cancer, Cancers , 3, (1), 2011, p1426-1453Journal Article, 2011, DOI , URL , TARA - Full Text
  • Kenneth J. O'Byrne ; Anne-Marie Baird ; Lisa Kilmartin ; Jennifer Leonard ; Calen Sacevich ; Steven G. Gray, Epigenetic Regulation of Glucose Transporters in Non-Small Cell Lung Cancer, Cancers , 3, (2), 2011, p1550-1565Journal Article, 2011, DOI , URL , TARA - Full Text
  • Gray, S.G., Easty, D., Baird, A., Soltermann, A., Nonaka, D., Fennell, D.A., Mutti, L., Pass, H.I., Opitz, I., O'Donnell, D., and O'Byrne, K.J. , The Macrophage Stimulating Protein (MSP)-RON/MST1R axis in malignant pleural mesothelioma, IASLC World Lung , Amsterdam, Netherlands , July 3-7, 2011, 2011Conference Paper, 2011
  • Easty, D., Gray, S.G., Baird, A., Soltermann, A., Nonaka, D., Fennell, D.A., Opitz, I., Pass, H.I., Mutti, L., O'Donnell, D.M., and O'Byrne, K.J. , MST1R, a receptor tyrosine kinase expressed in malignant pleural mesothelioma, Journal of Clinical Oncology, 29, 2011Journal Article, 2011
  • Busacca, S., Gray, S.G., Paul, I., McTavish, N., O'Byrne, K.J., Quinn, J.E., and Fennell, D.A. , BRCA1 expression and efficacy of vinorelbine in malignant mesothelioma, Journal of Clinical Oncology, 29, 2011Journal Article, 2011
  • Baird, AM; Gray, SG; O'Byrne, KJ , Expression of the CXC (ELR plus ) receptor, CXCR2, is reactivated by epigenetic means in non-small cell lung cancer, Lung Cancer, 71, 2011Journal Article, 2011
  • Allott EH, Oliver E, Lysaght J, Gray SG, Reynolds JV, Roche HM, Pidgeon GP, The SGBS cell strain as a model for the in vitro study of obesity and cancer., Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 14, (10), 2012, p774-82Journal Article, 2012, DOI
  • Baird AM, Leonard J, Naicker KM, Kilmartin L, O'Byrne KJ, Gray SG, IL-23 is pro-proliferative, epigenetically regulated and modulated by chemotherapy in non-small cell lung cancer., Lung cancer (Amsterdam, Netherlands), 79, (1), 2013, p83-90Journal Article, 2013, DOI
  • Gray SG, Baird AM, O'Kelly F, Nikolaidis G, Almgren M, Meunier A, Dockry E, Hollywood D, Ekström TJ, Perry AS, O'Byrne KJ, Gemcitabine reactivates epigenetically silenced genes and functions as a DNA methyltransferase inhibitor., International journal of molecular medicine, 30, (6), 2012, p1505-11Journal Article, 2012, DOI
  • Baird AM, Gray SG, O'Byrne KJ, IL-20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF., European journal of cancer (Oxford, England : 1990), 47, (12), 2011, p1908-18Journal Article, 2011, DOI
  • Cathcart MC, Gray SG, Baird AM, Boyle E, Gately K, Kay E, Cummins R, Pidgeon GP, O'Byrne KJ, Prostacyclin synthase expression and epigenetic regulation in nonsmall cell lung cancer., Cancer, 117, (22), 2011, p5121-32Journal Article, 2011, DOI
  • Barr MP, Gray SG, Hoffmann AC, Hilger RA, Thomale J, O'Flaherty JD, Fennell DA, Richard D, O'Leary JJ, O'Byrne KJ., Generation and characterisation of Cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature., PloS one, 8, (1), 2013, pe54193Journal Article, 2013, DOI , URL , TARA - Full Text
  • Baird AM, O'Byrne KJ, Gray SG, Epigenetic regulation of chemokine/chemokine receptor expression., Methods in molecular biology (Clifton, N.J.), 1013, 2013, p185-201Journal Article, 2013, DOI
  • Baird AM, Dockry E, Daly A, Stack E, Doherty DG, O'Byrne KJ, Gray SG, IL-23R is Epigenetically Regulated and Modulated by Chemotherapy in Non-Small Cell Lung Cancer., Frontiers in oncology, 3, 2013, p162-Journal Article, 2013, DOI , TARA - Full Text
  • Manente AG, Valenti D, Pinton G, Jithesh PV, Daga A, Rossi L, Gray SG, O'Byrne KJ, Fennell DA, Vacca RA, Nilsson S, Mutti L, Moro L, Estrogen receptor ß activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo., Oncogenesis, 2, 2013, pe72Journal Article, 2013, DOI
  • Wright CM, Kirschner MB, Cheng YY, O'Byrne KJ, Gray SG, Schelch K, Hoda MA, Klebe S, McCaughan B, van Zandwijk N, Reid G, Long non coding RNAs (lncRNAs) are dysregulated in Malignant Pleural Mesothelioma (MPM)., PloS one, 8, (8), 2013, pe70940Journal Article, 2013, DOI , TARA - Full Text
  • Versteyhe S, Klaproth B, Borup R, Palsgaard J, Jensen M, Gray SG, De Meyts P, IGF-I, IGF-II, and Insulin Stimulate Different Gene Expression Responses through Binding to the IGF-I Receptor., Frontiers in endocrinology, 4, 2013, p98Journal Article, 2013
  • Barbone D, Cheung P, Battula S, Busacca S, Gray SG, Longley DB, Bueno R, Sugarbaker DJ, Fennell DA, Broaddus VC, Vorinostat eliminates multicellular resistance of mesothelioma 3D spheroids via restoration of Noxa expression., PloS one, 7, (12), 2012, pe52753Journal Article, 2012, DOI , TARA - Full Text
  • Busacca S, Sheaff M, Arthur K, Gray SG, O'Byrne KJ, Richard DJ, Soltermann A, Opitz I, Pass H, Harkin DP, Quinn JE, Fennell DA, BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma., The Journal of pathology, 227, (2), 2012, p200-8Journal Article, 2012
  • Hurwitz JL, Stasik I, Kerr EM, Holohan C, Redmond KM, McLaughlin KM, Busacca S, Barbone D, Broaddus VC, Gray SG, O'Byrne KJ, Johnston PG, Fennell DA, Longley DB, Vorinostat/SAHA-induced apoptosis in malignant mesothelioma is FLIP/caspase 8-dependent and HR23B-independent., European journal of cancer (Oxford, England : 1990), 48, (7), 2012, p1096-107Journal Article, 2012
  • Gray SG, Epigenetic treatment of neurological disease., Epigenomics, 3, (4), 2011, p431-50Journal Article, 2011

Recognition

  • Invited Speaker EFBIC Diabetes Workshop "Shifting paradigms in diabetes" February 26th 2009
  • ToPCaP (Transdisciplinary Prostate Cancer Partnership) - http://topcapteam.org/
  • iMiG (International Mesothelioma Interest Group)
  • ETOP (European Thoracic Oncology Program) - www.etop-eu.org
  • British Thoracic Oncology Group present
  • Editorial Board member World Journal of Biological Chemistry Dec 2013
  • Associate Editor: BMC Cancer 2019-present
  • Member of the Editorial Academy for the "International Journal of Oncology" https://www.spandidos-publications.com/pages/ijo/editorial 2016-present
  • Editorial Board Member The Open Diabetes Journal (Bentham http://www.bentham.org/open/todiaj/EBM.htm) from 2008 2008-2014
  • Grant reviewer Australian National Health and Medical Research Council (NHMRC) (2010, 2012, 2017) Austrian Science Fund (2011, 2019) Bulgarian Science Foundation (2008) British Lung Foundation (2010, 2020) Cancer Research UK (2009) Czech Science Foundation (2012) Cyprus Research Promotion Foundation (2011) The Dutch Organisation for Health Research and Development (ZonMw) (2017) The Eli and Edythe Broad Foundation - Broad Medical Research Program (2012) Enterprise Ireland Commercialisation Fund (2005, 2006, 2008) Eureka Eurostars Technical Experts (2015-2020) EU - H2020-Marie Skłodowska-Curie Actions (Reviewer -2020, 2021 ; Rapporteur, 2021) Fondation contre le Cancer - Belgium (2016) Fondazione Pisa - Italy (2016) Fondazione Regionale Per La Ricerca Biomedica [Lomardy Region] (2020, 2022) France's National Research Agency -ANR [Agence Nationale de la Recherche] (2008, 2011) German Research Foundation (2009) 2009-2022
  • Editorial Board: International Journal of Oncology 2016-present
  • Senior Board Member BMC Pulmonary Medicine 2020-present
  • Section Editor: Clinical Epigenetics (https://clinicalepigeneticsjournal.biomedcentral.com/about/editorial-board) 2018-present
  • Ad Hoc reviewer for the following journals (3): Neurogenetics, Neurological Research, Neuropsychiatric Disease and Treatment, the Open Diabetes Journal, Oncology Reports, OncoTarget, PLoS One, Pharmaceutical Patent Analyst, Pharmacological Research, Pharmacogenomics, Phytotherapy Research, Progress in Lipid Research, Stem Cells, Theranostics, Translational Research, Trends in Neurosciences, Trends in Molecular Medicine
  • Associate Editor: PLoS One 2018-present
  • Grant Reviewer (2): German-Israeli Foundation (2011) HRB Medical Charities Research Group (2008) IASLC (2011, 2012, 2013 on behalf of Professor Kenneth J. O'Byrne) INNOVATION FUND DENMARK (2015). Italian Telethon Foundation (2008) Multiple Sclerosis Society (UK) (2012) MRC Medical Research Council (2020) The Netherlands Organisation for Scientific Research (NWO) - VENI program (2013) National Science Centre Poland (OPUS) (2015, 2017) OeNB Anniversary Fund (Austria) (2014, 2015) OTKA - Hungarian Scientific Research Fund (2014, 2015) Prostate Cancer UK (2014) Prostate Cancer Research Centre (2019) Wellcome Trust (2009) Worldwide Cancer Research (2021) Swiss Cancer League (2010, 2018) 2004-2022
  • Deputy Editor for the Epigenetic Regulators section of the Targeted Proteins database and Epigenetic Regulators section of the CBD Protein Systems journal (launched 2008) 2008 - present
  • Independent Reporter for GenomeBiology (www.genomebiology.com) (2001)
  • Editorial Board: Cancers (MDPI) 2017-present
  • Editorial Board member "World Journal of Experimental Medicine" (2011-2019) 2011-2019
  • Founding Editorial Board Member "Clinical Epigenetics" 2009-present
  • Editorial Board Member "Frontiers in Systems Physiology" (Review Editor, Systems Biology) http://www.frontiersin.org/systems_physiology
  • Invited "ad hoc" contributor to Trends in Genetics Short In Brief Articles section (2001-2002)
  • Ad Hoc Journal Reviewer for the following: Acta Neuropathologica, Aging, Antioxidants & Redox Signaling, BBA-Reviews on Cancer, BBA - Gene Regulatory Mechanisms, BioEssays, BMC Medical Genetics, BMC Urology, British Journal of Cancer, British Journal of Clinical Pharmacology, British Journal of Pharmacology, Cancer, Cancers (MDPI),Cancer Epidemiology, Cancer Immunology Research, Cancer Letters, Cancer Research, Clinical and Experimental Rheumatology, Cell Biochemistry and Biophysics, Cellular & Molecular Life Sciences, CNS & Neurological Disorders-Drug Targets (CNSND-DT), Clinical Cancer Research, Clinical Lung Cancer, Cytokine, Diabetologia, E-Biomedicine, Epigenetics, European Journal of Cell Biology, European Journal of Pharmacology, Experimental Cell Research, Expert Opinion On Investigational Drugs, Expert Opinion on Therapeutic Targets
  • Steering Committee Mesothelioma Research Network Steering Group (UK) (2018 - 2022) 2018-2022
  • Panel Member: The International Cancer Genome Consortium (workgroup: Renal Cancer) 2008 to present
  • Associate Editor Molecular and Structural Endocrinology (specialty section of Frontiers in Endocrinology) 2018-present
  • Ad hoc reviewer for various journals (2): Future Oncology - Epigenomics, Frontiers in Systems Biology, Genes & Cancer, Genome Medicine, Hormone & Metabolic Research, Inflammation & Allergy - Drug Targets, International Journal of Cancer, International Journal of Immunogenetics, Irish Journal of Medical Science, Journal of Cellular & Molecular Medicine, Journal of Experimental and Molecular Pathology, Journal of Hematology & Oncology, The Journal of Pathology, Journal of Nucleic Acids, Journal of Thoracic Oncology, Life Sciences, Lung Cancer, Mini-Reviews in Medicinal Chemistry, Molecular Cancer Research, Molecular and Cancer Therapeutics, Molecular Therapy
  • Editorial Board: Cells (MDPI) 2019-present
  • Panel Member: The International Cancer Genome Consortium (workgroup: Renal Cancer) 2008-2010
  • Editorial Board member "Frontiers in Epigenomics" (Guest Associate Editor & Review Editor) http://www.frontiersin.org/Epigenomics